Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Amgen to pay hefty $13.4 billion for buying Celgene psoriasis drug Otezla

      Amgen to pay hefty $13.4 billion for buying Celgene psoriasis drug Otezla

      Medical Dialogues Bureau27 Aug 2019 9:15 AM IST
      Amgen, which announced the deal on Monday, is paying a hefty price for the drug, analysts and investors said. Still, Otezla will deliver growth for...
      CDSCO preparing list of dual-use APIs imported from unregistered firms

      CDSCO preparing list of dual-use APIs imported from unregistered firms

      Medical Dialogues Bureau26 Aug 2019 2:23 PM IST
      "The Central Drugs Standard Control Organisation (CDSCO), the Ministry of Health and the Department of Pharmaceuticals want to put a stop to the...
      Alkem Labs gets 4 USFDA observations for St Louis facility

      Alkem Labs gets 4 USFDA observations for St Louis facility

      Medical Dialogues Bureau26 Aug 2019 12:39 PM IST
      New Delhi: Drugmaker Alkem Laboratories (Alkem Labs) recently informed that the company has received four observations from the US health regulator...
      Lupin, Glenmark recall hypertension, fungal infection drugs from US market

      Lupin, Glenmark recall hypertension, fungal infection drugs from US market

      Medical Dialogues Bureau26 Aug 2019 9:45 AM IST
      New Delhi: Pharma major Glenmark is recalling over 31,000 tubes of anti-fungal Clotrimazole and Betamethasone Dipropionate cream from the US market,...
      GSK Belantamab Mafodotin shows to help blood cancer patients

      GSK Belantamab Mafodotin shows to help blood cancer patients

      Medical Dialogues Bureau26 Aug 2019 9:15 AM IST
      Two doses of Belantamab Mafodotin helped subdue the disease in adults who had received three prior treatments for multiple myeloma, a cancer of the...
      Opioid Lawsuit: Oklahoma judge to deliver judgment in first state case

      Opioid Lawsuit: Oklahoma judge to deliver judgment in first state case

      Medical Dialogues Bureau26 Aug 2019 9:00 AM IST
      Oklahoma Attorney General Mike Hunter has called consumer products giant JnJ, the last remaining defendant group in the case, a "kingpin" company that...
      CDSCO issues advisory on Labelling requirements for MTP combo kit of Misoprostol, Mifepristone tablet, Details

      CDSCO issues advisory on Labelling requirements for MTP combo kit of Misoprostol, Mifepristone tablet, Details

      Medical Dialogues Bureau25 Aug 2019 1:30 PM IST
      New Delhi: The apex drug regulatory body, Central Drugs Standard Control Organisation(CDSCO) has recently issued an advisory on labelling requirements...
      HDFC gets CCI nod for buying 51.2 pc stake in Apollo Munich Health for Rs 1347 crore

      HDFC gets CCI nod for buying 51.2 pc stake in Apollo Munich Health for Rs 1347 crore

      Medical Dialogues Bureau25 Aug 2019 10:00 AM IST
      In June, HDFC agreed to acquire Apollo Hospitals Group's entire 50.8 per cent stake in Apollo Munich Health for Rs 1,336 crore and also the 0.4 per...
      Novo Nordisk files suit against Mylan to block entry of generic Victoza drug in US

      Novo Nordisk files suit against Mylan to block entry of generic Victoza drug in US

      Medical Dialogues Bureau25 Aug 2019 9:50 AM IST
      “We can confirm that Novo Nordisk has filed a lawsuit against Mylan for patent infringement of Victoza,” the company said in an e-mail.COPENHAGEN:...
      GSK two-drug HIV injection shows promising result

      GSK two-drug HIV injection shows promising result

      Medical Dialogues Bureau25 Aug 2019 9:30 AM IST
      The long-acting needle-based combination of its drug cabotegravir and Janssen's treatment rilpivirine met its main goal in the study, which was...
      Lawmakers push Mylan, Teva Pharma over drug pricing probe

      Lawmakers push Mylan, Teva Pharma over drug pricing probe

      Medical Dialogues Bureau25 Aug 2019 9:10 AM IST
      U.S. House Oversight Chairman Elijah Cummings, along with U.S. Senator Bernie Sanders, the ranking member on the Senate Budget Committee, sent the...
      OxyContin maker Purdue Pharma agrees to provide proprietary research, other data

      OxyContin maker Purdue Pharma agrees to provide proprietary research, other data

      Medical Dialogues Bureau25 Aug 2019 9:00 AM IST
      OKLAHOMA CITY: The maker of the powerful painkiller OxyContin has agreed to provide access to proprietary research and other data to researchers at...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok